Purchase Order HHSN272201200275P
- Not listed
- This firm fixed-price purchase order contract was awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) on September 16, 2015 for $19,603.58. The contract, which does not have a set-aside designation, is for the provision of Illumina's sequencing systems, reagents, and consumables to support genomic sequencing and analysis for research and diagnostic purposes. Illumina has previously received prime federal contracts and sub-awards from agencies such as...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $70,000.00 contract is for the provision of various Illumina sequencing systems, reagents, and consumables to support genomic sequencing and analysis for research and diagnostic purposes. The contract has no set-aside designation. Illumina has previously...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...
- This is a $32,754.46 firm fixed price delivery order contract awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract provides Illumina's sequencing systems, reagents, and associated services to support genomic research and diagnostics. No set-aside was used. Illumina has previously received other prime federal contract and subcontract awards from agencies like the NIH,...
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The $8,734 firm fixed-price contract is for the delivery of Illumina's sequencing systems, reagents, and related services to support genomic research and analysis. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract has no set-aside designation....
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $3,161.60 and is for the provision of Illumina's sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic applications. The contract does not have a set-aside designation. Based on Illumina's history...
- This firm-fixed price delivery order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $120,084.75 contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has previously been awarded prime federal contracts and subcontracts to support genomic sequencing and analysis across government agencies like the NIH, CDC, USDA, and VA. This...
- This is a firm fixed price Purchase Order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $11,937.60, is for the provision of unspecified "OTHER FUNCTIONS" and does not have a set-aside designation. Through past prime federal contract awards, Illumina has provided a range of goods and services, including sequencing...
- This is a firm fixed price Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. for $15,564.92. The contract provides Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic purposes. No set-aside designation was used. Illumina has previously received prime contract awards from agencies like the...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for $48,000.00. The award is to provide service and support for Illumina's Genome Analyzer Illumina sequencing systems. Illumina is a manufacturer and provider of genetic and genomic sequencing and analysis instruments and reagents. This award does not have a set-aside designation. Illumina has a history of...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The award, valued at $40,892.00, is for the provision of Illumina's products and services to support genomic sequencing and analysis. Illumina has previously been awarded prime federal contracts and subcontracts by various agencies like the NIH, CDC, USDA, and VA to provide a range of their sequencing platforms, reagents, and bioinformatics tools. This contract does not have a set-aside designation. Illumina also holds an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery worth up to $3.3 million to support nucleic acid sequencing needs.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Illumina Service Support | NOI-RML-2013 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 2/17/12, 11:59 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.9k | 3/2/12 |